Hughes Steven George bought RNA
August 13, 2025 · Form 4 insider transaction
Hughes Steven George bought 1,542 shares of Atrium Therapeutics, Inc. at $6.57 per share, a transaction worth $10.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,542
Price
$6.57
Total value
$10.1K
InsiderHughes Steven George
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 13, 2025
Filing dateAugust 15, 2025
Shares owned after40,409
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.